Announcements
Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Original Research
Mid-trimester maternal serum hCG levels in predicting adverse pregnancy outcome
Show Less
1
Department of Obstetrics and Gynaecology
2
Department of Nuclear Medicine
3
Department of Medical Physics, University of Patras Medical School, Rion (Greece)
Clin. Exp. Obstet. Gynecol. 2009, 36(3), 173–175;
Published: 10 September 2009
Abstract
Objective: In this prospective study, we investigated the association between mid-trimester maternal serum human chorionic gonadotropin (ms-hCG) levels and adverse pregnancy outcome in a South-Western Greek population. Materials and Methods: 130 healthy Greek women with spontaneous pregnancies were investigated for ms-hCG levels between the 13th and 24th weeks of gestation and followed for adverse pregnancy outcome. hCG levels > 2.0 multiples of the median value for gestation were considered abnormal. Statistical analysis was performed by Pearson’s chi-square test. Results: Gestational complications developed in a total of 12 of the 130 women studied (9.23%). Elevated ms-hCG levels were detected in a total of 14 of the 130 women studied (10.77%). Conclusion: Multiparameter testing of placental function in the mid-trimester (uterine artery Doppler, placental morphology and ms-hCG screening) may allow us to identify women with increased risk of developing severe placental insufficiency and pregnancy complications.
Keywords
Maternal serum hCG levels
Adverse pregnancy outcome